Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SnoreMeds is a commercial sleep-health and consumer medical-device company focused on anti-snoring mouthpieces. Its core product is a custom-moldable mandibular advancement device designed to reposition the lower jaw during sleep and improve airway patency, with products marketed in men’s and women’s sizes. The company sells primarily through online channels and appears to have distribution across the United States, South Africa, Australia, and New Zealand. SnoreMeds is not a drug-development biotech or pharma company; rather, it is a healthcare-related device brand centered on non-invasive snoring relief and related sleep-wellness products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SnoreMeds.